Skip to main content
. 2020 Apr 2;40(7):1545–1555. doi: 10.1111/liv.14408

FIGURE 2.

FIGURE 2

Economic impact of scenarios as measured by screening costs, direct medical costs, QALYs gained relative to the status quo and 13‐year ICER, by scenario, 2018‐2031. EUR, euros; ICER, incremental cost‐effectiveness ratio; QALYs, quality‐adjusted life year